Important roles of CD32 in promoting suppression of IL-4 induced immune responses by a novel anti-IL-4Rα therapeutic antibody

References

• Oh CK, Geba GP, Molfino N. Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur Respir Rev. 2010;19(115):46–54. doi:10.1183/09059180.00007609.
   PubMedGoogle Scholar
• Barranco P, Phillips-Angles E, Dominguez-Ortega J, Quirce S. Dupilumab in the management of moderate-to-severe asthma: the data so far. Ther Clin Risk Manag. 2017;13:1139–49. doi:10.2147/TCRM.S125964.
   PubMed Web of Science ®Google Scholar
• Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999;17:701–38. doi:10.1146/annurev.immunol.17.1.701.
   PubMed Web of Science ®Google Scholar
• Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B, Pirozzi G, Sutherland ER, Joish VN, Eckert L, et al. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomized double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet. 2016:1–14. doi:10.1016/S0140-6736(16)30307-5.
   PubMed Web of Science ®Google Scholar
• Stewart R, Hammond SA, Oberst M, Wilkinson RW. The role of Fc gamma receptors in the activity of immunomodulatory antibodies for cancer. J Immunother Cancer. 2014;2:29. doi:10.1186/s40425-014-0029-x.
   Google Scholar
• Irani V, Guy AJ, Andrew D, Beeson JG, Ramsland PA, Richards JS. Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases. Mol Immunol. 2015;67:171–82. doi:10.1016/j.molimm.2015.03.255.
   PubMed Web of Science ®Google Scholar
• Mellor JD, Brown MP, Irving HR, Zalcberg JR, Dobrovic A. A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer. J Hematol Oncol. 2013;6:1. doi:10.1186/1756-8722-6-1.
   PubMed Web of Science ®Google Scholar
• Kenkre VP, Hong F, Cerhan JR, Lewis M, Sullivan L, Williams ME, Gascoyne RD, Horning SJ, Kahl BS. Fc gamma receptor 3A and 2A polymorphisms do not predict response to rituximab in Follicular lymphoma. Clin Cancer Res. 2016;22(4):821–26. doi:10.1158/1078-0432.CCR-15-1848.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Fcg receptors as regulators of immune responses. Nat Rev Immunol. 2008;8:34–47. doi:10.1038/nri2206.
   PubMed Web of Science ®Google Scholar
• Dahan R, Emanuela S, Engelhardt J, Selby M, Korman AJ, Ravetch JV. FcgRs modulate the anti-tumor activity of antibodies targeting the PD-1/PD-L1 Axis. Cancer Cell. 2015;28:285–95. doi:10.1016/j.ccell.2015.08.004.
   PubMed Web of Science ®Google Scholar
• Bruhns P, Iannascoli B, England P, Mancardi DA, Femandez N, Jorieux S, Daeron M. Specificity and affinity of human Fcα receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113:3716–25. doi:10.1182/blood-2008-09-179754.
   PubMed Web of Science ®Google Scholar
• Hogarth PM, Pietersz GA. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nat Rev Drug Discov. 2012;11:311–31. doi:10.1038/nrd2909.
   PubMed Web of Science ®Google Scholar
• Grubczak K, Moniuszko M. The role of different monocyte subsets and macrophages in asthma pathogenesis. Prog Health Sci. 2015;5:176–84.
   Google Scholar
• Zaslona Z, Przybranowski S, Wilke C, Rooijen NV, Teitz-Tennenbaum S, Osterholzer JJ, Wilkinson JE, Moore BB, Peters-Golden M. Resident alveolar macrophages suppress, whereas recruited monocytes promote, allergic lung inflammation in murine models of asthma. J Immunol. 2014;193:4245–53. doi:10.4049/jimmunol.1400580.
   PubMed Web of Science ®Google Scholar
• Alevy YG, Tucker J, Mohanakumar T. CD32A (FcgRIIa) mRNA expression and regulation in blood monocytes and cell lines. Mol Immunol. 1992;29:1289–97.
   PubMed Web of Science ®Google Scholar
• Mullazehi M, Mathsson L, Lampa J, Ronnelid J. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor a, interleukin-1b, and interleukin-8 from peripheral blood monocytes via Fcg receptor IIa. Arthritis Rheumatism. 2006;54:1759–71. doi:10.1002/art.21892.
   PubMedGoogle Scholar
• Horton HM, Chu SY, Ortiz EC, Pong E, Cemerski S, Leung IWL, Jacob N, Zalevsky J, Desjarlais JR, Stohl W, et al. Antibody-mediated coengagement of FcαRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. J Immunol. 2011;186:4223–33. doi:10.4049/jimmunol.1003412.
   PubMed Web of Science ®Google Scholar
• Crowley JE, Stadanlick JE, Cambier JC, Cancro MP. FcgRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation. Blood. 2009;113:1464–73. doi:10.1182/blood-2008-02-138651.
   PubMed Web of Science ®Google Scholar
• Chu SY, Vostiar I, Karki S, Moore GL, Lazar GA, Pong E, Joyce PF, Szymkowski DE, Desjarlais JR. Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgRIIb with Fc-engineered antibodies. Mol Immunol. 2008;45:3926–33. doi:10.1016/j.molimm.2008.06.027.
   PubMed Web of Science ®Google Scholar
• Tridandapani S, Siefker K, Teillaud J, Carter JE, Wewers MD, Anderson CL. Regulated expression and inhibitory function of FcγRIIb in human monocytic cells. J Biol Chem. 2002;277:5082–89. doi:10.1074/jbc.M110277200.
   PubMed Web of Science ®Google Scholar
• Roghanian A, Stopforth RJ, Dahal LN, Cragg MS. New revelations from an old receptor: immunoregulatory functions of the inhibitory Fc gamma receptor, FcgRIIB (CD32B). J Leukoc Biol. 2018;1–12. DOI:10.1002/JLB.2MIR0917-354R
   Web of Science ®Google Scholar
• Boruchov AM, Heller G, Veri M, Bonvini E, Ravetch JV, Young JW. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest. 2005;115:2914–23. doi:10.1172/JCI24772.
   PubMed Web of Science ®Google Scholar
• Vercelli D, Leung DYM, Jabara HH, Geha RS. Interleukin 4 dependent induction of IgE synthesis and CD23 expression by the supernatants of a human helper T cell clone. Int Arch Allergy Appl Immunol. 1989;88:119–21.
   PubMedGoogle Scholar
• Williams J, Johnson S, Mascali JJ, Smith H, Rosenwasser LJ, Borish L. Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. J Immunol. 1992;149:2823–29.
   PubMed Web of Science ®Google Scholar
• Tantisira KG, Silverman ES, Mariani TJ, Xu J, Richter BG, Klanderman BJ, Litonjua AA, Lazarus R, Rosenwasser LJ, Fuhlbrigge AL, et al. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol. 2007;120:1285–91. doi:10.1016/j.jaci.2007.09.005.
   PubMed Web of Science ®Google Scholar
• Dunn-Siegrist I, Leger O, Daubeuf B, Poitevin Y, Depis F, Herren S, Kosco-Vilbois M, Dean Y, Pugin J, Elson G. Pivotal involvement of Fc gamma receptor IIA in the neutralization of LPS signaling via a potent novel anti-TLR4 monoclonal antibody, 15C1. J Biol Chem. 2007;282:34817–27. doi:10.1074/jbc.M706440200.
   PubMed Web of Science ®Google Scholar
• Mkaddem SB, Hayem G, Jonsson F, Rossato E, Boedec E, Boussetta T, Benna JE, Launay P, Goujon J, Benhamou M, et al. Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis. J Clin Invest. 2014;124:3945–59. doi:10.1172/JCI74572.
   PubMed Web of Science ®Google Scholar
• Conrad DH, Ford JW, Sturgill JL, Gibb DR. CD23: an overlooked regulator of allergic disease. Curr Allergy Asthma Rep. 2007;7:331–37.
   PubMed Web of Science ®Google Scholar
• Rankin CT, Veri M, Gorlatov S, Tuaillon N, Burke S, Huang L, Inzunza HD, Li H, Thomas S, Johnson S, et al. CD32B, the human inhibitory Fc-g receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma. Blood. 2006;108:2384–91. doi:10.1182/blood-2006-05-020602.
   PubMed Web of Science ®Google Scholar
• Li X, Wu J, Ptacek T, Redden DT, Brown EE, Alarcon GS, Ramsey-Goldman R, Petri MA, Reveille JD, Kaslow RA, et al. Allelic-dependent expression of an activating Fc Receptor on B cells enhances humoral immune responses. Sci Transl Med. 2013;5:1–10. doi:10.1126/scitranslmed.3007097.
   Web of Science ®Google Scholar
• Payet-Jamroz M, Helm SL, Wu J, Kilmon M, Fakher M, Basalp A, Tew JG, Szakal AK, Noben-Trauth N, Conrad DH. Suppression of IgE responses in CD23-Transgenic animals is due to expression of CD23 on nonlymphoid cells. J Immunol. 2001;166:4863–69.
   PubMed Web of Science ®Google Scholar
• Chan MA, Gigliotti NM, Matangkasombut P, Gauld SB, Cambier JC, Rosenwasser LJ. CD23-mediated cell signaling in human B cells differs from signaling in cells of the monocytic lineage. Clin Immunol. 2010;137:330–36. doi:10.1016/j.clim.2010.08.005.
   PubMed Web of Science ®Google Scholar
• Hershey GKK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol. 2003;111:677–90.
   PubMed Web of Science ®Google Scholar
• Hwang WYK, Almagro JC, Buss TN, Tan P, Foote J. Use of human germline genes in a CDR homology-based approach to antibody humanization. Methods. 2005;36:35–42. doi:10.1016/j.ymeth.2005.01.004.
   PubMed Web of Science ®Google Scholar
• Johnson LS, Huang L U.S. Patent No. 9,284,375. 2016. Washington, DC: U.S. Patent and Trademark office.
   Google Scholar
• Francis J, Amirkhosravi A, Meyer T, Robles-Carrillo L U.S. Patent No. 9,382,321. 2016. Washington, DC: U.S. Patent and Trademark office.
   Google Scholar